Release Date: 02/12/16 17:11 Summary: Change of Director's Interest Notice x3 Price Sensitive: No Download Document 96.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%